PerpEquities

Boston Scientific Corporation (BSX) balance sheet

NYSE · Healthcare · Medical - Devices · 59,000 employees · CEO Michael F. Mahoney

Price
$41.98 -1.66%
Market cap
$60.8B
Enterprise value
$72.9B
Last report
Q3 '26 filed 2026-09-30
Next report
2027-02-03 EPS est. $0.79

At the end of Q2 '26 Boston Scientific Corporation (BSX) held $539M in cash and short-term investments against $12.6B of debt incl. leases. Total assets $45.2B, total liabilities $20B, shareholders' equity $24.9B.

Balance sheet

Balance sheetTrendQ3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Assets
Cash & equivalents$952M$865M$2.33B$2.91B$2.5B$414M$725M$534M$1.28B$2.05B$1.52B$539M
Receivables$2.1B$2.23B$2.3B$2.4B$2.5B$2.56B$2.69B$2.82B$2.83B$2.93B$3.03B$3.05B
Inventory$2.4B$2.48B$2.56B$2.61B$2.75B$2.81B$2.87B$2.86B$2.92B$2.94B$3.12B$3.24B
Other current assets$740M$622M$672M$755M$673M$831M$756M$613M$701M$580M$658M$760M
Current assets$6.5B$6.51B$8.19B$8.99B$8.76B$6.92B$7.34B$7.12B$8.04B$8.79B$8.68B$7.97B
Property, plant & equipment (net)$3.08B$3.3B$3.33B$3.37B$3.5B$3.74B$3.84B$3.95B$4.29B$4.5B$4.61B$4.13B
Long-term investments$427M$413M$429M$589M$532M$555M$655M$626M$792M$842M$935M$2.25B
Goodwill$13.6B$14.4B$14.4B$14.4B$15B$17.1B$17.3B$18.1B$18.2B$18.3B$18.5B$18.6B
Intangible assets$5.85B$6B$5.84B$5.42B$5.75B$6.68B$6.57B$7.26B$7.16B$7.02B$7.06B$6.92B
Deferred tax assets$3.84B$3.84B$3.79B$3.8B$3.82B$3.66B$3.68B$3.78B$3.67B$3.68B$3.95B$3.91B
Other non-current assets$732M$679M$737M$546M$684M$749M$732M$746M$546M$559M$573M$1.41B
Non-current assets$27.5B$28.6B$28.5B$28.1B$29.3B$32.5B$32.8B$34.4B$34.7B$34.9B$35.7B$37.2B
Total assets$34B$35.1B$36.7B$37.1B$38.1B$39.4B$40.1B$41.6B$42.7B$43.7B$44.4B$45.2B
Liabilities
Accounts payable$929M$942M$921M$906M$907M$960M$1B$962M$1B$1.14B$1.14B$1.23B
Accrued expenses$912M$1.05B$749M$948M$1.11B$2.6B$2.22B$2.67B$2.83B$1.43B$0$2.76B
Short-term debt$513M$531M$1.09B$1.58B$1.65B$1.78B$777M$480M$483M$389M$41M$1.71B
Taxes payable$352M$220M$257M$224M$332M$268M$294M$173M$174M$299M$0$390M
Deferred revenue$246M$266M$280M$284M$290M$306M$306M$313M$309M$313M$0$0
Other current liabilities$1.63B$1.92B$1.62B$1.63B$1.66B$491M$439M$597M$531M$2.17B$3.39B$732M
Current liabilities$4.58B$4.93B$4.92B$5.58B$5.91B$6.4B$5.06B$5.19B$5.33B$5.44B$4.57B$6.43B
Long-term debt$8.38B$8.57B$9.53B$8.99B$9.23B$8.84B$10.4B$11B$11B$11.5B$10.9B$10.8B
Lease obligations (non-current)$404M$395M$386M$369M$377M$527M$525M$566M$570M$571M$124M$124M
Deferred revenue (non-current)$301M$311M$314M$316M$328M$329M$335M$349M$359M$369M$0$0
Deferred tax liabilities$91M$134M$132M$132M$138M$155M$158M$226M$242M$220M$219M$221M
Other non-current liabilities$1.16B$1.27B$1.22B$1.12B$1.14B$1.14B$1.21B$1.59B$1.59B$1.14B$2.47B$2.48B
Non-current liabilities$10.3B$10.7B$11.6B$10.9B$11.2B$11B$12.6B$13.7B$13.7B$13.8B$13.7B$13.6B
Total liabilities$14.9B$15.6B$16.5B$16.5B$17.1B$17.4B$17.7B$18.9B$19.1B$19.2B$18.2B$20B
Equity
Common stock & paid-in capital$17M$17M$17M$17M$17M$17M$17M$17M$17M$17M$17M$17M
Retained earnings$315M$819M$1.31B$1.64B$2.11B$2.67B$3.35B$4.14B$4.9B$5.57B$6.91B$7.82B
Accumulated other comprehensive income$231M$49M$133M$164M-$128M$275M-$28M-$722M-$689M-$610M-$398M-$304M
Shareholders' equity$18.9B$19.3B$19.9B$20.4B$20.7B$21.8B$22.2B$22.4B$23.4B$24.2B$25.9B$24.9B
Debt
Total debt (incl. leases)$9.3B$9.49B$11B$10.9B$11.3B$11.1B$11.7B$12B$12B$12.4B$11B$12.6B
Net debt (debt - cash)$8.35B$8.63B$8.67B$8.02B$8.76B$10.7B$11B$11.5B$10.8B$10.4B$9.51B$12.1B

Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30

Data as of 2026-11-01